Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 5, 2007

BioSeek to Ally with UCB for Compound Evaluation

  • BioSeek and UCB will jointly evaluate a number of UCB compounds across several target classes in support of target differentiation, lead development, and drug candidate selection using BioSeek’s BioMAP® Systems.

    BioMAP Systems are a series of human primary cell-based assays designed to replicate cell and pathway interactions in human disease biology. BioMAP profiling provides characterization of drug function including defining mechanism of action and secondary activities and can provide insights into potential clinical applications, according to BioSeek.

    In addition to characterizing previously identified lead compounds, BioSeek is using BioMAP for primary screening to rapidly generate lead compounds that have novel activity in a particular disease setting.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »